Home ASCO15: AngioChem Presents ANG1005 Data On Breast Cancer Patients...
 

Keywords :   


ASCO15: AngioChem Presents ANG1005 Data On Breast Cancer Patients...

2015-06-02 00:37:09| Logistics - Topix.net

Angiochem, a clinical stage biotechnology company creating and developing drugs that cross the blood-brain barrier, today announced that results from an ongoing multi-center Phase II study were presented on Saturday, May 30, 2015 at the 2015 American Society for Clinical Oncology annual meeting being held in Chicago. The trial was designed to evaluate the activity of ANG1005, a novel taxane-peptide conjugate able to cross the blood brain barrier and enter cancer cells by targeting the LRP-1 receptor, in metastatic breast cancer patients.

Tags: data cancer presents patients

Category:Transportation and Logistics

Latest from this category

All news

01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
31.10Atlantic Tropical Weather Outlook
31.10Eastern North Pacific Tropical Weather Outlook
31.10Atlantic Tropical Weather Outlook
31.10Eastern North Pacific Tropical Weather Outlook
31.10Eastern North Pacific Tropical Weather Outlook
31.10Atlantic Tropical Weather Outlook
Transportation and Logistics »
01.11Boeing makes 38% pay rise offer in bid to end strike
01.11The house paints that promise much more than colour
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11How Japan's youngest CEO transformed Hello Kitty
31.10Unicharm to Expand in Africa
More »